Research Paper on:
An Overdoes of Intravenous Medication and a Change Theory Application

Unformatted Sample Text from the Research Paper:
Ironically, it can also take place in what is ostensibly most safe environment for the delivery of intravenous drugs -- the clinical setting of a modern hospital. The  student working on this project should understand that horror stories such as what happened to award-winning journalist Betsy Lehman have are always reasons to make both medical care providers and  the general public worry about their safety and the drugs they are given while in the hospital. Lehman was a patient at Dana-Farber Cancer Institute in 1995, one of  the worlds leading hospitals in the field. She died as the result of being given four times the normal dose of the cancer drug cyclophosphamide. To make matters worse, another  Dana-Farber patient received the same overdose two days before. The Problem For the purposes of this research, intravenous medication overdose in a medium-sized hospital setting is considered and addressed.  When a patient is admitted to the hospital and is receiving intravenous drugs, it is clear that he or she is already in a relatively fragile state. The  student researching this should consider that in order to obtain the overall incidence of overdose of intravenously administered medications, it will be necessary to combine the incidence of overdoses occurring  while in the hospital plus the incidence of symptoms and/or disease that would have initially required use of the medication. In order to assure that only the incidence of  IV overdose of legitimate medication is addressed, it will be important to discount errors in drug administration, noncompliance, drug abuse, therapeutic failures, and possible adverse drug reactions (ADRs). According to  Lazarou, Pomeranz, and Corey (1998), the incidence of serious and fatal drug reactions in U.S. hospitals is extremely high. It would certainly appear that appropriate drug dosage, as well as